Glucocorticoid-induced adrenal insufficiency

JAMA

Volumn 282, Issue 7, 1999, Pages 671-676

  Krasner, Alan S ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTISONE ACETATE; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; METHYLPREDNISOLONE; METYRAPONE; PREDNISOLONE; PREDNISONE; TRIAMCINOLONE;

ADRENAL INSUFFICIENCY; ADULT; ARTICLE; ASTHMA; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DRUG WITHDRAWAL; ENDOCRINE FUNCTION TEST; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0033581220     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.7.671     Document Type: Article

References (37)

1. Kountz DS, Clark CL. Safely withdrawing patients from chronic glucocorticoid therapy. Am Fam Physician. 1997;55:521-525.
2. Byyny RL. Withdrawal from glucocorticoid therapy. N Engl J Mod. 1976;295:30-32.
3. Amatruda TT Jr, Hollingsworth DR, D'Esopo ND, Upton CV, Bondy PK. A study of the mechanism of the steroid withdrawal syndrome: evidence for integrity of the hypothalamic-pituitary-adrenal system. J Clin Endocrinol Metab. 1960;20:339-354.
4. Papanicolaou DA, Tsigos C, Oldfield EH, Chrousos GP. Acute glucocorticoid deficiency is associated with plasma elevations of interleukin-6: does the latter participate in the symptomatology of the steroid withdrawal syndrome and adrenal insufficiency? J Clin Endocrinol Metab. 1996;81:2303-2306.
5. Dixon RB, Christy NP. On the various forms of corticosteroid withdrawal syndrome. Am J Med. 1980; 68:224-230.
6. Jasani MK, Boyle JA, Greig WR, et al. Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis. QJM. 1967;36: 261-276.
7. Axelrod L. Glucocorticoid therapy. Medicine. 1976; 55:39-65.
8. Schlaghecke R, Kornely E, Santen RT, Ridderskamp P. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med. 1992;326: 226-230.
9. May ME, Carey RM. Rapid adrenocorticotropic hormone test in practice: retrospective review. Am J Med. 1985;79:679-684.
10. Streeten DHP, Anderson GH Jr, Bonaventura MM. The potential for serious consequences from misinterpreting normal responses to the rapid adrenocorticotropin test. J Clin Endocrinol Metab. 1996;81: 285-290.
11. Fish HR, Chernow B, O'Brian JT. Endocrine and neurophysiologic responses of the pituitary to insulin-induced hypoglycemia: a review. Metabolism. 1986; 35:763-780
12. Abdu TA, Elhadd TA, Neary R, Clayton RN. Comparison of the low dose short synacthen test (1 μg), the conventional dose short synacthen test (250 μg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab. 1999;84: 838-843.
13. Dickstein G, Arad E, Shechner C. Low-dose ACTH stimulation test. Endocrinologist. 1997;7:285-293.
14. Streeten DH. Shortcomings In the low-dose (1 μg) ACTH test for the diagnosis of ACTH deficiency states [editorial]. J Clin Endocrinol Metab. 1999;84:835-837.
15. Mayenknecht J, Dlederich S, Bähr V, Plöckinger U, Oelkers W. Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease. J Clin Endocrinol Metab. 1998;83:1558-1562.
16. Weintrob N, Sprecher E, Josefsberg Z, et al. Standard and low-dose short adrenocorticotropin test compared with insulin-induced hypoglycemia for assessment of the hypothalamic-piturtary-adrenal axis in children with idiopathic multiple pituitary hormone deficiencies. J Clin Endocrinol Metab. 1998;83:88-92.
17. Christy NP. Pituitary-adrenal function during corticosteroid therapy: learning to live with uncertainty [editorial]. N Engl J Med. 1992;326:266-267.
18. Melby JC. Systemic corticosterold therapy: pharmacology and endocrinologic considerations. Ann Intern Med. 1974;81:505-512.
19. Yaffe SJ, Aranda JV, eds. Pediatric Pharmacology, 2nd ed. Philadelphia, Pa: WB Saunders; 1992:466.
20. Harter JG. Corticosteroids: their physiologic use in allergic disease. N Y State J Med. 1966;66:827-840.
21. Ackerman GL, Nolan CM. Adrenocortical responsiveness after alternate-day corticosteroid therapy. N Engl J Med. 1968;278:405-409.
22. Nichols T, Nugent CA, Tyler FH. Diurnal variation in suppression of adrenal function by glucocorticoids. J Clin Endocrinol. 1965;25:343-349
23. Carrella MJ, Srivastava LS, Gossain W, Rovner DR. Hypothalamic-pituitary-adrenal function one week after a short burst of steroid therapy. J Clin Endocrinol Metab. 1993;76:1188-1191.
24. Streck WF, Lockwood DH. Pituitary adrenal recovery following short-term suppression with corticosteroids. Am J Med. 1979;66:910-914.
25. LaRochelle GE Jr, LaRochelle AG, Ratner RE, Borensteln DG. Recovery of the hypothalamic-pituitary-adrenal (HPA) axis in patients with rheumatic diseases receiving low-dose prednisone. Am J Med. 1993; 95:258-264.
26. Kirwan JR and the Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med. 1995;333:142-146.
27. Laan RF, van Riel PL, van de Putte LB, van Eming LJ, van't Hof MA, Lemmens JA. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis: a randomized, controlled study. Ann Intern Med. 1993;119:963-968.
28. Zelissen PM, Croughs RJ, van Rijk PP, Raymakers JA. Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease. Ann Intern Med. 1994;120:207-210.
29. Esteban NV, Loughlin T, Yergey AL, et al. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab. 1991;71:39-45.
30. Orth DN. Adrenal insufficiency. In: Bardin CW, ed. Current Therapy in Endocrinology and Metabolism. 5th ed. St Louis, Mo: Mosby-Year Book Inc; 1994: 124-130.
31. Salem M, Tainsh RE Jr, Bromberg J, Loriaux DL, Chernow B. Perioperative glucocorticoid coverage: a reassessment 42 years after emergence of a problem. Ann Surg. 1994;219:416-425.
32. Glowniak JV, Loriaux DL. A double-blind study of perioperative steroid requirements in secondary adrenal insufficiency. Surgery. 1997;121:123-129.
33. Jasani MK, Freeman PA, Boyle JA. Reid AM, Diver MJ, Buchanan WW. Studies of the rise in plasma 11-hydroxycorticosteroids (11-OHCS) in corticosteroid-treated patients with rheumatoid arthritis during surgery: correlations with the functional integrity of the hypothalamo-pituitary-adrenal axis. QJM. 1968;37: 407-421.
34. Thygeson NM. Preoperative assessment of adrenal insufficiency in glucocorticoid therapy [letter]. Arch Intern Med. 1984;144:2288.
35. Carter ME, James VH. Effect of alternate-day, single-dose, corticosteroid therapy on pituitary-adrenal function. Ann Rheum Dis. 1972;31:379-383.
36. Carter ME, James VH. An attempt at combining corticotrophin with long-term corticosteroid therapy with a view to preserving hypothalamic-pituitary-adrenal function. Ann Rheum Dis. 1970;29:409-414.
37. Graber AL, Ney RL, Nicholson WE, Island DP, Liddle GW. Natural history of pituitary-adrenal recovery following long-term suppression with corticosteroids. J Clin Endocrinol Metab. 1965;25:11-16.